Rare Diseases Emerging Therapies
Rare Diseases affect a small percent of the population, however, the collective burden of rare disease is quite high. As per the estimates, approximately, 300 million people, around the world, are living with one or other 6,000 identified rare diseases.
Rare Disease is still a field that remains largely unexplored owing to rarity and dispersed patient pool. However, with an increase in awareness, and collective efforts from private and public enterprises, rare diseases are getting much wider attention at the world level. Today some of the key players such as Albireo, Hyperion Therapeutics, Ravicti, Ucyclyd Pharma, Takeda, Evox Therapeutics, and many others are actively involved in developing therapies for Rare Diseases.
To read more about Rare Diseases namely Synovial Sarcoma, Biliary Atresia, & Argininosuccinic Aciduria and their available treatment modalities, and upcoming therapies, visit: Rare Diseases Emerging Therapies